Sep 25, 2023 4:05 pm EDT Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost
Sep 21, 2023 8:00 am EDT Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13
Sep 19, 2023 4:45 pm EDT Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference
Aug 2, 2023 4:30 pm EDT Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to Follow
Jun 2, 2023 1:40 pm EDT Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases